Charles Schwab sold $6.6m on Monday and gave away $3.0m on Tuesday — and the filings cannot tell you why
| Date | Code | Shares | Price | Balance after |
|---|---|---|---|---|
| 3 Nov 2026 | S — sale | 11,675 | $89.21 | 53,334,616 |
| 9 Nov 2026 | S — sale | 70,750 | wtd $93.0074 ($92.835–$93.135) | 53,263,866 |
| 10 Nov 2026 | G — bona fide gift | 31,850 | $0 | 53,232,016 |
All on the trust line. Other reported indirect holdings: 30,021,463 by a limited partnership, 10,624,797 by his spouse as trustee, 44,025 by 188 Corp.
Form 4, SCHW, Schwab Charles R. (co-chairman, director), txns 9–10 Nov 2026, accepted 10 Nov 20:09 ET, signature dated 10 Nov. Preceding Form 4, txn 3 Nov 2026. The three balances chain exactly: 53,334,616 − 70,750 = 53,263,866; 53,263,866 − 31,850 = 53,232,016. That reconciliation is why this item is marked confirmed despite running through two filings and two aggregators.
An 89-year-old founder trims a sliver and makes a charitable gift. Total movement is 0.19% of the trust line over seven sessions, against a stake worth roughly $4.95bn on that line alone. There is nothing to read here, and the financial press will — correctly — not write about it at all.
The sale is noise; the sequence is the item. He sold 6.1× more shares on 9 November than on 3 November, at a 4.3% higher price, and gifted the next day. That ordering — raise cash, then transfer appreciated stock — is the signature of a dated transfer plan running to a year-end, not of a man reacting to a share price. The useful question is not whether he is selling. It is which transfer calendar he is on.
What the documents say: three dated transactions, two codes, exact balances. What they do not say: the gift recipient, whether a Rule 10b5-1 plan exists, and whether the sale and the gift are connected at all. Inference The one-day gap is suggestive; it is not proof of a link.
The honest position is that the motive is not knowable from this evidence. Three hypotheses are live, and each has a different observable consequence:
- (a) Year-end charitable transfer. Appreciated stock to a donor-advised fund or charity before 31 December; the sale funds something unrelated. Distinguishing test: further G codes in December, and a Form 5 in February covering small gifts not reported in real time.
- (b) Estate-planning transfer. Shares moved to a family trust or GRAT, with the sale covering the tax or the annuity. Distinguishing test: a new indirect holder line appearing on the next Form 4 — the trust line splitting is the tell.
- (c) Routine diversification plus unrelated giving. No link at all. Distinguishing test: S-code sales continuing at a similar cadence through Q1 with no further G codes.
I am not going to pick one. Nothing in the window separates them, and the size ratio — 0.13% of the trust line sold — rules out any reading in which this expresses a view on Schwab stock. That is the only firm conclusion available.
The claim being made is narrow: that this is calendar-driven and carries no view on the stock. It is wrong if December brings a sale an order of magnitude larger — say above 700,000 shares, 10× the 9 November print — or if a Form 144 appears proposing a seven-figure share count. Either would mean November was the leading edge of a real reduction rather than plumbing.
Within the window: 11,675 shares (3 Nov) → 70,750 (9 Nov) = 6.1× at a 4.3% higher price. Net position change across the seven sessions: 53,334,616 → 53,232,016, down 0.19%. For scale, the 9 November sale raised about $6.58m against a trust-line stake worth roughly $4.95bn.